Health state utility and quality of life measures in patients with chronic myeloid leukemia in France
Author:
Funder
Agence Nationale de la Recherche
Institut de Recherche en Santé Publique
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Link
https://link.springer.com/content/pdf/10.1007/s11136-021-02794-5.pdf
Reference36 articles.
1. Apperley, J. F. (2015). Chronic myeloid leukaemia. Lancet (London, England), 385(9976), 1447–1459. https://doi.org/10.1016/S0140-6736(13)62120-0.
2. Le Guyader-Peyrou, S., Belot, A., Maynadié, M., Binder-Foucard, F., Remontet, L., Troussard, X., et al. (2016). Cancer incidence in France over the 1980–2012 period: Hematological malignancies. Revue D’epidemiologie Et De Sante Publique, 64(2), 103–112. https://doi.org/10.1016/j.respe.2015.12.017.
3. Höglund, M., Sandin, F., & Simonsson, B. (2015). Epidemiology of chronic myeloid leukaemia: An update. Annals of Hematology, 94(Suppl 2), S241-247. https://doi.org/10.1007/s00277-015-2314-2.
4. Foulon, S., Cony-Makhoul, P., Guerci-Bresler, A., Delord, M., Solary, E., Monnereau, A., et al. (2019). Using healthcare claims data to analyze the prevalence of BCR-ABL-positive chronic myeloid leukemia in France: A nationwide population-based study. Cancer Medicine, 8(6), 3296–3304. https://doi.org/10.1002/cam4.2200.
5. Bower, H., Björkholm, M., Dickman, P. W., Höglund, M., Lambert, P. C., & Andersson, T.M.-L. (2016). Life expectancy of patients with chronic myeloid leukemia approaches the life expectancy of the general population. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 34(24), 2851–2857. https://doi.org/10.1200/JCO.2015.66.2866.
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Measuring chronic myeloid leukaemia TKI-related toxic effects in the real world: a systematic review and critical assessment of content validity of patient-reported outcome measures;The Lancet Haematology;2023-10
2. A Multicenter Retrospective Chart Review Study of Treatment and Disease Patterns and Clinical Outcomes of Patients with Chronic-Phase Chronic Myeloid Leukemia in Third-Line Treatment or with T315I Mutation;Cancers;2023-08-18
3. BRAF Mutations in Melanoma: Biological Aspects, Therapeutic Implications, and Circulating Biomarkers;Cancers;2023-08-08
4. Quality‐of‐life, mental health, and perspective on TKI dose reduction as a prelude to discontinuation in chronic phase chronic myeloid leukemia;Cancer Medicine;2023-07-06
5. Health-related quality of life of patients with resistant/intolerant chronic phase chronic myeloid leukemia treated with asciminib or bosutinib in the phase 3 ASCEMBL trial;Leukemia;2023-04-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3